ampelopsin has been researched along with cyclic gmp in 1 studies
| Studies (ampelopsin) | Trials (ampelopsin) | Recent Studies (post-2010) (ampelopsin) | Studies (cyclic gmp) | Trials (cyclic gmp) | Recent Studies (post-2010) (cyclic gmp) |
|---|---|---|---|---|---|
| 377 | 2 | 343 | 22,346 | 333 | 4,062 |
| Protein | Taxonomy | ampelopsin (IC50) | cyclic gmp (IC50) |
|---|---|---|---|
| Phosphodiesterase | Bos taurus (cattle) | 0.1 | |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase B | Homo sapiens (human) | 2.4 | |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase A | Homo sapiens (human) | 2.4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Meng, G; Yang, S; Yao, W; Zhang, W; Zhu, H | 1 |
1 other study(ies) available for ampelopsin and cyclic gmp
| Article | Year |
|---|---|
Attenuating effects of dihydromyricetin on angiotensin II-induced rat cardiomyocyte hypertrophy related to antioxidative activity in a NO-dependent manner.
Topics: Angiotensin II; Animals; Animals, Newborn; Antioxidants; Cell Size; Cell Survival; Cyclic GMP; Flavonols; Mitogen-Activated Protein Kinases; Myocytes, Cardiac; Nitric Oxide; Nitric Oxide Synthase Type III; Primary Cell Culture; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species | 2015 |